Life Science Investing Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
Life Science Investing Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units